Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.

Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients.

BACKGROUND: Cytomegalovirus infection in renal transplant recipients is a major clinical problem, with both short and long term sequelae. Infection can occur as a result of reactivation of latent virus or new infection from donor tissues. The impact of donor and recipient serostatus on viremia is w...

書誌詳細
主要な著者:	Hughes, D, Hafferty, J, Fulton, L, Friend, P, Devaney, A, Loke, J, Welsh, K, Handa, A, Klenerman, P
フォーマット:	Journal article
言語:	English
出版事項:	2008

類似資料

How Do Donor-recipient CMV Serostatus and Post-hematopoietic Stem Cell Transplantation CMV Reactivation Affect Outcomes in Acute Leukemia Patients?
著者:: Mohammad Vaezi, 等
出版事項: (2016-10-01)

CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays
著者:: Castro Ana, 等
出版事項: (2001-05-01)

Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients
著者:: Jumpei Hasegawa, 等
出版事項: (2017-12-01)

QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection
著者:: Paolo Solidoro, 等
出版事項: (2024-08-01)

Low-dose valaciclovir prophylaxis against cytomegalovirus disease in renal transplant recipients.
著者:: Reddy, S, 等
出版事項: (2003)

Cytomegalovirus Serostatus and Functional Impairment in Liver Transplant Recipients in the Current Era
著者:: Nina Singh, 等
出版事項: (2021-08-01)

DETERMINAZIONE DI CMV-ANTIGENEMIA E DI CMV-DNA QUANTITATIVO: TRE ANNI DI ESPERIENZA.
著者:: A. Rossi, 等
出版事項: (2007-09-01)

MONITORING OF CMV INFECTION IN KIDNEY TRANSPLANT RECIPIENTS
著者:: Zhivka Stoykova, 等
出版事項: (2017-12-01)

Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients
著者:: Jonathan P. Law, 等
出版事項: (2021-03-01)

Patient years lost due to cytomegalovirus serostatus mismatching in the scientific registry of transplant recipients
著者:: Maheen Z. Abidi, 等
出版事項: (2024-01-01)

Combined Analysis of Early CD4<sup>+</sup> T Cell Counts and CMV Serostatus May Improve CMV Risk Assessment after Allogeneic Hematopoietic Cell Transplantation
著者:: Saskia Leserer, 等
出版事項: (2021-11-01)

Anti-CMV serostatus correlates with shortened progression free- and overall survival in patients with glioblastoma
著者:: H. Krenzlin, 等
出版事項: (2021-01-01)

COMPARAZIONE DEI VALORI DI ANTIGENEMIA E VIREMIA DA CMV IN PAZIENTI TRAPIANTATI RENALI.
著者:: C. Di Natale, 等
出版事項: (2005-09-01)

IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.
著者:: Jean Elcheikh
出版事項: (2013-04-01)

DIAGNOSTICA PRECOCE DEL CMV: ANTIGENEMIA E DNA (PCR REAL TIME) A CONFRONTO
著者:: E. Mascheroni, 等
出版事項: (2005-09-01)

Prevention and management of CMV infection in pediatric solid organ transplant recipients
著者:: Shanthi S. Balani, 等
出版事項: (2023-02-01)

CMV-associated adrenal insufficiency in a renal transplant recipient
著者:: Nilesh Tejura, 等
出版事項: (2018-01-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
著者:: Hyeyoung Lee, 等
出版事項: (2017-01-01)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.
著者:: Jong Man Kim, 等
出版事項: (2015-01-01)

“Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
著者:: Ifigeneia Tzannou, 等
出版事項: (2019-09-01)

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
著者:: Katya Prakash, 等
出版事項: (2021-05-01)

CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors
著者:: Ambreen Azhar, 等
出版事項: (2022-12-01)

Long-term CMV monitoring and chronic rejection in renal transplant recipients
著者:: Shoko Ishikawa, 等
出版事項: (2023-06-01)

COMPARAÇÃO ENTRE TÉCNICAS DE IMUNOISTOQUÍMICA E DE IMUNOFLUORESCÊNCIA PARA ANTIGENEMIA PP65 DO CITOMEGALOVÍRUS (CMV) EM RECEPTORES DE TRANSPLANTE
著者:: Regina Barbosa Schroeder, 等
出版事項: (2009-03-01)

Factors influencing CMV seropositivity in stem cell transplant patients and donors
著者:: Per Ljungman, 等
出版事項: (2007-08-01)

CMV Infection and Lymphopenia: Warning Markers of Pneumocystis Pneumonia in Kidney Transplant Recipients
著者:: Isabelle Eberl, 等
出版事項: (2024-01-01)

Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients
著者:: M. H. Karimi, 等
出版事項: (2011-10-01)

Bridging the gap: assessing CMV DNAemia in kidney transplant recipients with previous solid organ transplants
著者:: Goni Katz-Greenberg, 等
出版事項: (2024-04-01)

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells
著者:: Helen M McGuire, 等
出版事項: (2020-01-01)

A Systematic Review and Meta-analysis of Optimized CMV Preemptive Therapy and Antiviral Prophylaxis for CMV Disease Prevention in CMV High-Risk (D+R-) Kidney Transplant Recipients
著者:: Lakshin Kumar, 等
出版事項: (2023-08-01)

INFEZIONE DA CYTOMEGALOVIRUS (CMV): UN CONFRONTO TRA ANTIGENEMIA E UN TEST QUANTITATIVO IN REAL TIME PCR
著者:: C. Giraldi, 等
出版事項: (2007-09-01)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
著者:: Procter, J, 等
出版事項: (2009)

CMV and the art of memory maintenance.
著者:: Klenerman, P, 等
出版事項: (2008)

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
著者:: Isabelle P. Lodding, MD, 等
出版事項: (2018-06-01)

Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients
著者:: Richard Ahn, 等
出版事項: (2021-11-01)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.
著者:: Isabelle Poizot-Martin, 等
出版事項: (2016-01-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
著者:: Procter, J, 等
出版事項: (2009)

Complement and renal transplantation: from donor to recipient.
著者:: Damman, J, 等
出版事項: (2008)

Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
著者:: Heinrike Wilkens, 等
出版事項: (2016-01-01)

Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients
著者:: Smaranda Gliga, 等
出版事項: (2021-01-01)